vs
Side-by-side financial comparison of Bloomin' Brands, Inc. (BLMN) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $975.2M, roughly 1.5× Bloomin' Brands, Inc.). Bloomin' Brands, Inc. runs the higher net margin — -1.4% vs -13.6%, a 12.2% gap on every dollar of revenue. On growth, Bloomin' Brands, Inc. posted the faster year-over-year revenue change (0.3% vs -5.3%). Organon & Co. produced more free cash flow last quarter ($96.0M vs $63.7M). Over the past eight quarters, Organon & Co.'s revenue compounded faster (-3.6% CAGR vs -4.5%).
Bloomin' Brands, Inc. is a restaurant holding company that owns several American casual dining restaurant chains. The company was established in 1988 in Tampa, Florida, where it is headquartered.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
BLMN vs OGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $975.2M | $1.5B |
| Net Profit | $-13.5M | $-205.0M |
| Gross Margin | 70.2% | 49.2% |
| Operating Margin | -1.4% | -9.8% |
| Net Margin | -1.4% | -13.6% |
| Revenue YoY | 0.3% | -5.3% |
| Net Profit YoY | 83.0% | -288.1% |
| EPS (diluted) | $-0.16 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $975.2M | $1.5B | ||
| Q3 25 | $928.8M | $1.6B | ||
| Q2 25 | $1.0B | $1.6B | ||
| Q1 25 | $1.0B | $1.5B | ||
| Q4 24 | $972.0M | $1.6B | ||
| Q3 24 | $910.0M | $1.6B | ||
| Q2 24 | $999.4M | $1.6B | ||
| Q1 24 | $1.1B | $1.6B |
| Q4 25 | $-13.5M | $-205.0M | ||
| Q3 25 | $-45.9M | $160.0M | ||
| Q2 25 | $25.4M | $145.0M | ||
| Q1 25 | $42.2M | $87.0M | ||
| Q4 24 | $-79.5M | $109.0M | ||
| Q3 24 | $6.9M | $359.0M | ||
| Q2 24 | $28.4M | $195.0M | ||
| Q1 24 | $-83.9M | $201.0M |
| Q4 25 | 70.2% | 49.2% | ||
| Q3 25 | 70.4% | 53.5% | ||
| Q2 25 | 70.2% | 54.8% | ||
| Q1 25 | 70.1% | 55.6% | ||
| Q4 24 | 71.6% | 56.3% | ||
| Q3 24 | 71.3% | 58.3% | ||
| Q2 24 | 70.5% | 58.4% | ||
| Q1 24 | 70.5% | 59.0% |
| Q4 25 | -1.4% | -9.8% | ||
| Q3 25 | -3.9% | 15.2% | ||
| Q2 25 | 3.0% | 14.4% | ||
| Q1 25 | 5.5% | 6.7% | ||
| Q4 24 | 1.7% | 8.1% | ||
| Q3 24 | 0.9% | 13.1% | ||
| Q2 24 | 4.4% | 14.6% | ||
| Q1 24 | 6.6% | 14.5% |
| Q4 25 | -1.4% | -13.6% | ||
| Q3 25 | -4.9% | 10.0% | ||
| Q2 25 | 2.5% | 9.1% | ||
| Q1 25 | 4.0% | 5.8% | ||
| Q4 24 | -8.2% | 6.8% | ||
| Q3 24 | 0.8% | 22.7% | ||
| Q2 24 | 2.8% | 12.1% | ||
| Q1 24 | -7.8% | 12.4% |
| Q4 25 | $-0.16 | $-0.78 | ||
| Q3 25 | $-0.54 | $0.61 | ||
| Q2 25 | $0.30 | $0.56 | ||
| Q1 25 | $0.50 | $0.33 | ||
| Q4 24 | $-0.93 | $0.42 | ||
| Q3 24 | $0.08 | $1.38 | ||
| Q2 24 | $0.32 | $0.75 | ||
| Q1 24 | $-0.96 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $59.5M | $574.0M |
| Total DebtLower is stronger | $787.4M | $8.6B |
| Stockholders' EquityBook value | $333.6M | $752.0M |
| Total Assets | $3.2B | $12.9B |
| Debt / EquityLower = less leverage | 2.36× | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $59.5M | $574.0M | ||
| Q3 25 | $66.5M | $672.0M | ||
| Q2 25 | $50.3M | $599.0M | ||
| Q1 25 | $57.7M | $547.0M | ||
| Q4 24 | $70.1M | $675.0M | ||
| Q3 24 | $83.6M | $763.0M | ||
| Q2 24 | $117.9M | $704.0M | ||
| Q1 24 | $131.7M | $575.0M |
| Q4 25 | $787.4M | $8.6B | ||
| Q3 25 | $962.2M | $8.8B | ||
| Q2 25 | $917.1M | $8.9B | ||
| Q1 25 | $917.6M | $9.0B | ||
| Q4 24 | $1.0B | $8.9B | ||
| Q3 24 | $1.1B | $8.7B | ||
| Q2 24 | $1.0B | $8.7B | ||
| Q1 24 | $951.8M | $8.7B |
| Q4 25 | $333.6M | $752.0M | ||
| Q3 25 | $344.1M | $906.0M | ||
| Q2 25 | $397.2M | $733.0M | ||
| Q1 25 | $380.6M | $542.0M | ||
| Q4 24 | $135.5M | $472.0M | ||
| Q3 24 | $242.1M | $493.0M | ||
| Q2 24 | $286.8M | $144.0M | ||
| Q1 24 | $302.7M | $48.0M |
| Q4 25 | $3.2B | $12.9B | ||
| Q3 25 | $3.3B | $13.6B | ||
| Q2 25 | $3.3B | $13.5B | ||
| Q1 25 | $3.3B | $13.2B | ||
| Q4 24 | $3.4B | $13.1B | ||
| Q3 24 | $3.4B | $12.8B | ||
| Q2 24 | $3.4B | $12.2B | ||
| Q1 24 | $3.4B | $11.9B |
| Q4 25 | 2.36× | 11.49× | ||
| Q3 25 | 2.80× | 9.74× | ||
| Q2 25 | 2.31× | 12.14× | ||
| Q1 25 | 2.41× | 16.52× | ||
| Q4 24 | 7.58× | 18.81× | ||
| Q3 24 | 4.51× | 17.75× | ||
| Q2 24 | 3.49× | 60.11× | ||
| Q1 24 | 3.14× | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $119.1M | $141.0M |
| Free Cash FlowOCF − Capex | $63.7M | $96.0M |
| FCF MarginFCF / Revenue | 6.5% | 6.4% |
| Capex IntensityCapex / Revenue | 5.7% | 3.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $96.8M | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $119.1M | $141.0M | ||
| Q3 25 | $34.4M | $264.0M | ||
| Q2 25 | $49.7M | $220.0M | ||
| Q1 25 | $73.5M | $75.0M | ||
| Q4 24 | $119.8M | $390.0M | ||
| Q3 24 | $-7.8M | $141.0M | ||
| Q2 24 | $42.4M | $332.0M | ||
| Q1 24 | $73.8M | $76.0M |
| Q4 25 | $63.7M | $96.0M | ||
| Q3 25 | $-5.7M | $218.0M | ||
| Q2 25 | $11.1M | $181.0M | ||
| Q1 25 | $27.7M | $43.0M | ||
| Q4 24 | $66.7M | $335.0M | ||
| Q3 24 | $-67.3M | $99.0M | ||
| Q2 24 | $-12.1M | $300.0M | ||
| Q1 24 | $20.0M | $30.0M |
| Q4 25 | 6.5% | 6.4% | ||
| Q3 25 | -0.6% | 13.6% | ||
| Q2 25 | 1.1% | 11.4% | ||
| Q1 25 | 2.6% | 2.8% | ||
| Q4 24 | 6.9% | 21.0% | ||
| Q3 24 | -7.4% | 6.3% | ||
| Q2 24 | -1.2% | 18.7% | ||
| Q1 24 | 1.9% | 1.8% |
| Q4 25 | 5.7% | 3.0% | ||
| Q3 25 | 4.3% | 2.9% | ||
| Q2 25 | 3.8% | 2.4% | ||
| Q1 25 | 4.4% | 2.1% | ||
| Q4 24 | 5.5% | 3.5% | ||
| Q3 24 | 6.5% | 2.7% | ||
| Q2 24 | 5.5% | 2.0% | ||
| Q1 24 | 5.0% | 2.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.65× | ||
| Q2 25 | 1.95× | 1.52× | ||
| Q1 25 | 1.74× | 0.86× | ||
| Q4 24 | — | 3.58× | ||
| Q3 24 | -1.13× | 0.39× | ||
| Q2 24 | 1.49× | 1.70× | ||
| Q1 24 | — | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLMN
| Food And Beverage | $958.0M | 98% |
| Franchiseand Other Revenue | $17.2M | 2% |
| International Franchise Segment | $7.8M | 1% |
OGN
Segment breakdown not available.